A natural long-chain polymer, chitin is the main component of the cell walls of fungi, the exoskeletons of arthropods (including crustaceans and insects), the radulas of mollusks, and the beaks and internal shells of cephalopods. However, marine crustacean shells are the primary sources of the chitin derivative chitosan. Chitin and chitosan are useful for various biological and biomedical applications, although they have been limited by poor solubility in the past. Current research focuses on increasing their solubility and bioactivity through molecular modifications. The resulting derivatives are receiving much attention for interesting properties, such as biocompatibility, biodegradability, and nontoxicity, that make them suitable for use in the biomedical field
The Chitin and Chitosan Derivatives market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Chitin and Chitosan Derivatives industry. 
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain. 
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Chitin and Chitosan Derivatives market can be split based on product types, major applications, and important countries as follows:

Key players in the global Chitin and Chitosan Derivatives market covered in Chapter 12:
Kitozyme
Zhejiang Shinfuda Marine Biotechnology Corp.
Heppe Medical Chitosan GmbH
G.T.C. Bio Corporation
Zhejiang Candorly Pharmaceutical Co., Ltd
Golden-Shell Pharmaceutical Co., Ltd
Meron Biopolymers
Advanced Biopolymers AS
KYTOSAN USA, LLC
Kunpoong Bio Co., Ltd
Primex Ehf

In Chapter 4 and 14.1, on the basis of types, the Chitin and Chitosan Derivatives market from 2015 to 2025 is primarily split into:
Glucosamine
Chitosan
Others

In Chapter 5 and 14.2, on the basis of applications, the Chitin and Chitosan Derivatives market from 2015 to 2025 covers:
Water Treatment
Cosmetics & Toiletries
Food & Beverages
Healthcare/Medical
Agrochemicals
Biotechnology
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025